0,989  0,002  Chemoprotective
0,977  0,001  Antimutagenic
0,970  0,002  Monophenol monooxygenase inhibitor
0,960  0,004  Alpha-glucosidase inhibitor
0,954  0,003  Mutagenic
0,946  0,002  Genotoxic
0,944  0,002  NOS2 expression inhibitor
0,941  0,003  TNF expression inhibitor
0,938  0,003  Antioxidant
0,936  0,002  UGT1A9 substrate
0,932  0,002  Chemopreventive
0,930  0,002  Caspase 9 stimulant
0,928  0,001  Antihypoxic
0,913  0,002  Xanthine oxidase inhibitor
0,911  0,001  Amylase inhibitor
0,910  0,002  Proliferative diseases treatment
0,904  0,003  Radioprotector
0,903  0,004  Carcinogenic
0,900  0,003  Cardioprotectant
0,897  0,001  Antihemorrhagic
0,897  0,003  Free radical scavenger
0,878  0,004  Antihypercholesterolemic
0,874  0,002  UGT1A1 substrate
0,876  0,005  Antidiabetic
0,876  0,005  Cyclophilin D inhibitor
0,872  0,003  Vasodilator, coronary
0,865  0,008  Antiinflammatory
0,865  0,009  Transcription factor NF kappa B inhibitor
0,858  0,002  Sulfotransferase substrate
0,851  0,002  Carbonic anhydrase XIII inhibitor
0,850  0,002  Melanin inhibitor
0,849  0,004  Cytostatic
0,854  0,010  Apoptosis agonist
0,837  0,003  NOS3 expression inhibitor
0,816  0,002  Cystathionine beta-synthase inhibitor
0,816  0,002  Antihypotensive
0,816  0,004  Hypoglycemic
0,809  0,009  Teratogen
0,800  0,004  UDP-glucuronosyltransferase substrate
0,800  0,004  DNA damaging
0,787  0,004  Angiogenesis stimulant
0,777  0,010  Embryotoxic
0,758  0,005  Nitric oxide antagonist
0,755  0,004  Vascular (periferal) disease treatment
0,752  0,004  UGT1A6 substrate
0,750  0,004  AR expression inhibitor
0,751  0,005  Antibacterial
0,745  0,004  Skin whitener
0,740  0,006  Antithrombotic
0,729  0,004  Antihypertriglyceridemic
0,725  0,003  NOS3 expression enhancer
0,722  0,004  Apoptosis antagonist
0,720  0,005  Hepatic disorders treatment
0,717  0,005  Caspase 3 stimulant
0,707  0,008  Sensitization
0,691  0,003  Antidote
0,687  0,004  Hepatoprotectant
0,692  0,011  Respiratory analeptic
0,691  0,014  Antileukemic
0,689  0,013  CYP2C9 substrate
0,682  0,006  Antiparasitic
0,671  0,005  Tumour necrosis factor alpha release inhibitor
0,659  0,005  Amyloid beta aggregation inhibitor
0,657  0,006  Histamine release inhibitor
0,652  0,005  Antihelmintic
0,648  0,005  Ulceration
0,645  0,009  Spasmolytic
0,635  0,001  Nitric-oxide synthase stimulant
0,633  0,002  Protein kinase stimulant
0,644  0,013  Cholesterol antagonist
0,629  0,005  Antineoplastic (osteosarcoma)
0,628  0,008  Antipruritic, allergic
0,624  0,007  Antipyretic
0,619  0,004  Mediator release inhibitor
0,625  0,010  Cytotoxic
0,626  0,014  Immunostimulant
0,633  0,025  CYP3A4 substrate
0,610  0,007  Antiamyloidogenic
0,603  0,003  Beta glucuronidase inhibitor
0,598  0,003  Neurotrophic factor enhancer
0,597  0,003  VCAM1 expression inhibitor
0,620  0,032  Antineoplastic (breast cancer)
0,595  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,588  0,004  UGT2B4 substrate
0,590  0,006  RNA-directed DNA polymerase inhibitor
0,586  0,004  ICAM1 expression inhibitor
0,608  0,029  Antineoplastic (lung cancer)
0,592  0,015  CYP2C19 substrate
0,589  0,014  CTGF expression inhibitor
0,573  0,005  Non-steroidal antiinflammatory agent
0,568  0,004  Hemostatic
0,568  0,004  Lipid peroxidase inhibitor
0,572  0,010  Antiprotozoal (Leishmania)
0,565  0,003  AMP-activated protein kinase stimulant
0,561  0,003  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,572  0,016  Analeptic
0,573  0,017  5 Hydroxytryptamine release stimulant
0,559  0,004  Antitussive
0,565  0,015  Antineoplastic (pancreatic cancer)
0,558  0,013  Antifungal
0,553  0,008  Vasodilator
0,563  0,022  Prostate cancer treatment
0,545  0,005  Radiosensitizer
0,543  0,003  Carbonic anhydrase III inhibitor
0,564  0,027  Antineoplastic (colorectal cancer)
0,534  0,003  Cyclooxygenase 3 inhibitor
0,548  0,021  Immunosuppressant
0,524  0,004  Antifungal enhancer
0,537  0,018  Antineoplastic (cervical cancer)
0,521  0,004  Carcinogenic, group 1
0,531  0,023  Stroke treatment
0,526  0,019  Immunomodulator
0,509  0,002  Antihelmintic (Trematoda)
0,514  0,012  DNA synthesis inhibitor
0,501  0,003  Antiviral (Ebola)
0,503  0,005  Alkylator
0,499  0,004  UGT2B15 substrate
0,499  0,007  Topoisomerase II inhibitor
0,522  0,030  Antineoplastic (colon cancer)
0,514  0,028  5 Hydroxytryptamine release inhibitor
0,489  0,004  Interleukin 4 antagonist
0,496  0,013  Antineoplastic (lymphoma)
0,488  0,006  DNA methylase inhibitor
0,483  0,004  Aldose reductase substrate
0,477  0,004  NADPH oxidase inhibitor
0,480  0,011  Interleukin 2 agonist
0,478  0,010  Antineoplastic (sarcoma)
0,487  0,020  Antineoplastic (glioma)
0,478  0,012  Myocardial infarction treatment
0,474  0,009  Antiviral (Herpes)
0,488  0,025  CYP1A2 substrate
0,482  0,022  Antineoplastic (brain cancer)
0,463  0,005  DNA methyltransferase I inhibitor
0,461  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,456  0,004  UDP-glucose 4-epimerase inhibitor
0,454  0,004  Carbonic anhydrase VI inhibitor
0,464  0,013  Antineoplastic (liver cancer)
0,459  0,010  Cyclic AMP phosphodiesterase inhibitor
0,455  0,007  Platelet adhesion inhibitor
0,463  0,016  Antidiabetic symptomatic
0,471  0,025  Antiischemic
0,450  0,004  Hexokinase inhibitor
0,496  0,050  Alzheimer's disease treatment
0,447  0,003  Photosensitizer
0,471  0,031  Antineoplastic (ovarian cancer)
0,456  0,019  Antineoplastic (glioblastoma multiforme)
0,443  0,009  Carcinogenic, group 3
0,446  0,013  Interleukin agonist
0,458  0,026  Antiosteoporotic
0,432  0,004  Alcohol dehydrogenase inhibitor
0,430  0,003  Antiviral (Influenza B)
0,487  0,060  Antineoplastic (solid tumors)
0,430  0,004  Expectorant
0,460  0,035  Bone diseases treatment
0,440  0,024  Antidiabetic (type 2)
0,423  0,009  Interferon gamma antagonist
0,417  0,005  Topoisomerase I inhibitor
0,419  0,009  Antiviral (Influenza)
0,409  0,003  Selectin antagonist
0,408  0,005  Alkaline phosphatase inhibitor
0,433  0,034  Antineoplastic (melanoma)
0,395  0,005  Topoisomerase II alpha inhibitor
0,402  0,016  Septic shock treatment
0,401  0,019  Antineoplastic (small cell lung cancer)
0,391  0,012  Antineoplastic (squamous cell carcinoma)
0,409  0,030  Antineoplastic (multiple myeloma)
0,374  0,004  DNA repair enzyme inhibitor
0,417  0,050  Vasodilator, peripheral
0,425  0,059  Antiprotozoal
0,372  0,007  Glutathione S-transferase substrate
0,366  0,005  NADH dehydrogenase inhibitor
0,364  0,004  Interleukin 12 antagonist
0,380  0,023  Peroxidase inhibitor
0,432  0,078  Antiarthritic
0,362  0,010  Peptidyltransferase inhibitor
0,353  0,005  Dementia treatment
0,355  0,007  Aldehyde dehydrogenase inhibitor
0,350  0,003  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,350  0,004  Histone deacetylase stimulant
0,350  0,004  Histone deacetylase SIRT1 stimulant
0,350  0,005  Vascular dementia treatment
0,357  0,014  Antipruritic, non-allergic
0,348  0,007  Antineoplastic antibiotic
0,348  0,007  Psychosexual dysfunction treatment
0,362  0,027  Antiulcerative
0,344  0,009  Acute respiratory distress syndrome (ARDS) treatment
0,337  0,004  Aldose reductase inhibitor
0,341  0,016  UGT1A3 substrate
0,346  0,028  Antineoplastic enhancer
0,322  0,004  Triose-phosphate isomerase inhibitor
0,365  0,048  Lipoprotein disorders treatment
0,319  0,003  Carbonic anhydrase VII inhibitor
0,320  0,005  Antispirochetal
0,318  0,008  Gout treatment
0,352  0,043  Antineoplastic (non-small cell lung cancer)
0,333  0,023  P-glycoprotein inhibitor
0,326  0,020  Thrombolytic
0,308  0,005  Mannose-6-phosphate isomerase inhibitor
0,354  0,056  CYP2D6 substrate
0,310  0,011  Insulin secretagoues
0,349  0,056  Antimycobacterial
0,308  0,015  Antiviral (Influenza A)
0,288  0,004  Carbonic anhydrase XIV inhibitor
0,332  0,048  Huntington's disease treatment
0,324  0,043  Antineoplastic (renal cancer)
0,297  0,018  Antineoplastic (gastric cancer)
0,288  0,010  Cell wall synthesis inhibitor
0,297  0,022  Antineoplastic (carcinoma)
0,286  0,015  Antidiarrheal
0,310  0,040  Antineoplastic (lymphocytic leukemia)
0,273  0,004  Heat shock protein 70 antagonist
0,286  0,017  Interleukin 6 antagonist
0,280  0,013  Chelator
0,278  0,012  SULT1A3 substrate
0,287  0,021  Antihelmintic (Nematodes)
0,268  0,005  Creatine kinase inhibitor
0,270  0,007  Choleretic
0,272  0,009  ATPase inhibitor
0,269  0,007  Antineoplastic, alkylator
0,305  0,047  Interleukin antagonist
0,287  0,029  UGT2B7 substrate
0,303  0,047  Pyruvate kinase inhibitor
0,270  0,014  DNA polymerase I inhibitor
0,275  0,024  Protein-tyrosine phosphatase inhibitor
0,258  0,007  Phosphofructokinase-1 inhibitor
0,248  0,006  T cell inhibitor
0,249  0,009  Antibiotic
0,264  0,027  Insulin sensitizer
0,239  0,005  Thioredoxin inhibitor
0,236  0,003  Fatty acid synthase inhibitor
0,303  0,071  Metabolic disease treatment
0,254  0,025  Liver fibrosis treatment
0,269  0,042  Wound healing agent
0,230  0,004  Phosphodiesterase 6D inhibitor
0,233  0,012  Antifungal (Cryptococcus)
0,236  0,015  Carcinogenic, group 2B
0,228  0,007  Carbonic anhydrase XII inhibitor
0,284  0,065  CYP1A2 inhibitor
0,228  0,009  Uric acid excretion stimulant
0,256  0,041  Antialcoholic
0,218  0,003  Antibiotic Glycopeptide-like
0,217  0,005  Toll-Like receptor 4 antagonist
0,224  0,015  Retinoprotector
0,294  0,084  Antineoplastic (endocrine cancer)
0,271  0,062  Antineoplastic (bladder cancer)
0,212  0,004  Phosphodiesterase VI inhibitor
0,219  0,013  CF transmembrane conductance regulator agonist
0,230  0,024  Neuropathy treatment
0,213  0,009  Chronic obstructive bronchitis treatment
0,254  0,052  Antiviral (HIV)
0,220  0,020  Antirickettsial
0,209  0,012  Mucolytic
0,210  0,015  Anticataract
0,217  0,025  Protein-tyrosine phosphatase 1B inhibitor
0,265  0,073  Antiprotozoal (Trypanosoma)
0,220  0,028  Antineoplastic (bone cancer)
0,258  0,069  Platelet antagonist
0,306  0,117  Atherosclerosis treatment
0,198  0,009  Transcription factor NF kappa B stimulant
0,198  0,011  Multidrug resistance-associated protein 1 inhibitor
0,195  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,192  0,010  HIV-1 integrase (Strand Transfer) inhibitor
0,206  0,024  DNA intercalator
0,302  0,124  CYP2C19 inhibitor
0,193  0,017  UGT2B1 substrate
0,245  0,069  Hypolipemic
0,233  0,058  Anesthetic general
0,185  0,012  Carcinogenic, group 2A
0,181  0,009  Estrogen agonist
0,201  0,032  Antiprotozoal (Coccidial)
0,207  0,039  Cyclooxygenase inhibitor
0,172  0,005  Xanthine dehydrogenase inhibitor
0,170  0,004  Alpha-mannosidase inhibitor
0,252  0,085  Transcription factor STAT inhibitor
0,167  0,002  Sodium/glucose cotransporter inhibitor
0,166  0,004  Na+ K+ transporting ATPase inhibitor
0,163  0,002  Cholesterol absorption inhibitor
0,163  0,004  Mannosidase inhibitor
0,161  0,002  Arginase inhibitor
0,178  0,019  Vanilloid 1 agonist
0,171  0,013  NAD(P)H dehydrogenase (quinone) inhibitor
0,177  0,020  Gastritis treatment
0,181  0,023  SULT1A1 substrate
0,194  0,037  Antidiabetic (type 1)
0,208  0,054  Antiviral (Hepatitis)
0,184  0,029  Cell adhesion inhibitor
0,157  0,004  Antimycoplasmal
0,154  0,002  Sodium/glucose cotransporter 1 inhibitor
0,177  0,028  Adenylate cyclase stimulant
0,160  0,011  CDC25A inhibitor
0,169  0,021  HDL-cholesterol increasing
0,181  0,033  Toll-Like receptor 2 antagonist
0,154  0,007  Antiviral (Dengue virus)
0,193  0,047  Cystic fibrosis treatment
0,169  0,023  Falcipain inhibitor
0,166  0,022  Falcipain 2 inhibitor
0,180  0,038  Cyclooxygenase 2 inhibitor
0,161  0,020  Sphingomyelinase inhibitor
0,175  0,035  Antiviral (Hepatitis B)
0,154  0,014  SULT1E1 substrate
0,140  0,002  Sodium/glucose cotransporter 2 inhibitor
0,198  0,061  Diabetic retinopathy treatment
0,197  0,060  VEGF expression inhibitor
0,144  0,008  Phosphorylase inhibitor
0,145  0,009  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,186  0,055  Phospholipase C inhibitor
0,144  0,013  Interleukin 5 antagonist
0,138  0,009  Neuraminidase (influenza) inhibitor
0,137  0,008  Narcotic antagonist
0,167  0,039  Hearing loss treatment
0,161  0,034  Growth stimulant
0,150  0,023  Estrogen antagonist
0,181  0,058  Muscular dystrophy treatment
0,161  0,038  Adenylate cyclase inhibitor
0,153  0,032  Antineoplastic (uterine cancer)
0,188  0,067  Diabetic nephropathy treatment
0,175  0,057  Diuretic
0,122  0,003  Glucose-6-phosphate isomerase inhibitor
0,131  0,014  ATPase (Vacuolar H+) inhibitor
0,129  0,014  Interferon agonist
0,143  0,029  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,162  0,048  Acetylcholinesterase inhibitor
0,180  0,067  Dual specificity phosphatase inhibitor
0,163  0,050  Cyclooxygenase 1 inhibitor
0,121  0,010  Maillard reaction inhibitor
0,208  0,098  Aryl hydrocarbon receptor agonist
0,182  0,072  Dual specificity phosphatase 3 inhibitor
0,120  0,011  Antidote, heavy metal
0,172  0,064  Eye irritation, high
0,172  0,064  UGT2B10 substrate
0,219  0,112  Antituberculosic
0,198  0,092  Cardiodepressant
0,151  0,045  Antibacterial (Helicobacter pylori)
0,115  0,011  Neuraminidase inhibitor
0,122  0,017  Lipase inhibitor
0,164  0,061  Hair growth stimulant
0,112  0,010  Protein 50S ribosomal subunit inhibitor
0,183  0,081  Sedative
0,128  0,027  UGT2B11 substrate
0,100  0,003  Antibiotic Aminoglycoside-like
0,134  0,039  Transcription factor STAT6 inhibitor
0,108  0,013  CDC25B inhibitor
0,100  0,006  Glucose-6-phosphate translocase inhibitor
0,109  0,016  Postmenopausal disorders treatment
0,098  0,004  Heparanase inhibitor
0,092  0,003  Protein 30S ribosomal subunit inhibitor
0,151  0,064  Ribosomal protein S6 kinase inhibitor
0,098  0,013  Interferon inducer
0,106  0,024  Thioredoxin reductase inhibitor
0,235  0,154  Antiprotozoal (Plasmodium)
0,117  0,036  Estrogen receptor beta antagonist
0,104  0,023  HIV-1 integrase inhibitor
0,152  0,073  Antinephritic
0,090  0,011  Topoisomerase II beta inhibitor
0,159  0,080  UGT1A4 substrate
0,091  0,013  Estrogen receptor beta agonist
0,112  0,036  Actinic keratosis treatment
0,108  0,032  Glutamate release inhibitor
0,107  0,033  Antiviral (Trachoma)
0,141  0,070  Ca2+-transporting ATPase inhibitor
0,101  0,031  Glycine receptor antagonist
0,079  0,010  Adenosine deaminase inhibitor
0,089  0,026  Antitreponemal
0,121  0,059  Microtubule formation inhibitor
0,150  0,088  Antiviral (Hepatitis C)
0,215  0,153  Angiogenesis inhibitor
0,229  0,174  GABA C receptor rho-3 antagonist
0,078  0,024  Nitric oxide donor
0,231  0,178  Antineoplastic (non-Hodgkin's lymphoma)
0,099  0,046  Restless leg syndrome treatment
0,066  0,014  Estrogen receptor alpha agonist
0,121  0,070  M18 aspartyl aminopeptidase inhibitor
0,088  0,037  GABA aminotransferase inhibitor
0,100  0,050  Antiviral (Rhinovirus)
0,064  0,015  Equilibrative nucleoside transport protein inhibitor
0,097  0,049  Aminoacyl-tRNA synthetase inhibitor
0,108  0,059  MAO A inhibitor
0,124  0,077  Antiacne
0,051  0,003  Vanilloid 2 agonist
0,157  0,110  Psychostimulant
0,101  0,055  Breast cancer-resistant protein inhibitor
0,138  0,092  UGT2B9 substrate
0,117  0,072  Antifungal (Pneumocystis)
0,075  0,031  DNA gyrase inhibitor
0,064  0,021  Adenine nucleotide translocase inhibitor
0,051  0,008  Nucleoside transporters inhibitor
0,140  0,099  Uterine stimulant
0,154  0,114  Sepsis treatment
0,075  0,037  Carbonic anhydrase inhibitor
0,068  0,030  Protein kinase C eta inhibitor
0,102  0,064  Carbonic anhydrase XV inhibitor
0,076  0,040  Carbonic anhydrase VA inhibitor
0,057  0,021  Factor III inhibitor
0,079  0,045  Telomerase inhibitor
0,052  0,020  Neuraminidase (Influenza A) inhibitor
0,234  0,202  DNA directed DNA polymerase inhibitor
0,111  0,079  Constipation treatment
0,033  0,003  Telomerase stimulant
0,117  0,087  Contraceptive
0,107  0,078  Cholesterol synthesis inhibitor
0,032  0,003  Antibiotic Anthracycline-like
0,040  0,012  Uridine phosphorylase inhibitor
0,085  0,056  D-Ala-D-Ala ligase inhibitor
0,085  0,057  Vanilloid agonist
0,054  0,027  Antiviral (Herpesvirus 3, Human)
0,057  0,032  Leukotriene B4 antagonist
0,033  0,009  1,3-Beta-glucan synthase inhibitor
0,032  0,009  Toll-Like receptor 4 agonist
0,060  0,037  Lipocortins synthesis agonist
0,240  0,217  Calcium channel L-type activator
0,067  0,045  Carbonic anhydrase V inhibitor
0,075  0,054  SULT1A2 substrate
0,075  0,055  Arylamine N-Acetyltransferase substrate
0,028  0,009  GRP78 expression inhibitor
0,108  0,089  Alcohol dehydrogenase substrate
0,072  0,055  Adenosine A3 receptor antagonist
0,050  0,033  Squalene epoxidase inhibitor
0,204  0,189  GST M1-1 substrate
0,026  0,014  Adenosine A1 receptor agonist
0,024  0,014  Dopamine D1 agonist
0,076  0,067  Glutathione S-transferase inhibitor
0,033  0,025  Protein kinase C beta I inhibitor
0,113  0,107  Neurotrophic factor
0,060  0,054  Aryl hydrocarbon receptor antagonist
0,064  0,058  Histidine decarboxylase inhibitor
0,049  0,043  Carbonic anhydrase IX inhibitor
0,040  0,034  Guanylate cyclase inhibitor
0,063  0,058  Gaucher disease treatment
0,083  0,078  Protein kinase C zeta inhibitor
0,011  0,007  Purinergic P2Y2 agonist
0,100  0,096  Neutropenia treatment
0,015  0,014  Ileal bile acid transport inhibitor
0,012  0,011  Antibiotic Macrolide-like
0,050  0,049  Glucosylceramidase inhibitor
0,086  0,086  Anabolic
0,029  0,029  Catechol O-methyltransferase inhibitor

